PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsBacterial conjunctivitis
MeSH D003234 - bacterial conjunctivitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015818:Bacterial eye infections
$
Success rate
D003231:Conjunctivitis
D003234: 
Bacterial conjunctivitis
D003235:Inclusion conjunctivitis
0 Companies
0 Drugs
Success rate
D009878:Ophthalmia neonatorum
0 Companies
0 Drugs
Success rate
D014141:Trachoma
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCiprofloxacin Ciprofloxacin  2004-06-09   
Ofloxacin Ofloxacin  2003-09-02   
Taro PharmaceuticalCiprofloxacin Ciprofloxacin  2004-10-06   
NATCO PharmaCiprofloxacin Ciprofloxacin  2004-06-09   
Johnson & JohnsonOfloxacin Floxin  1990-12-28   
Lupin ResearchGatifloxacin Gatifloxacin  2013-08-28   
Loteprednol etabonate Loteprednol Etabonate  2023-12-26   
SandozGatifloxacin Gatifloxacin  2016-07-11   
Ofloxacin Ofloxacin  2004-05-14   
Ciprofloxacin Ciloxan  1990-12-31   
Hydrocortisone, Ciprofloxacin Cipro  1998-02-10   
Dexamethasone, Ciprofloxacin Ciprodex 2025-06-04 2003-07-18   
Bausch Health CompaniesLoteprednol etabonate Alrex  1998-03-09   
Besifloxacin Besivance 2029-11-13 2009-05-28   
Loteprednol etabonate Lotemax  1998-03-09   
Loteprednol etabonate Lotemax Sm 2036-01-26 2019-02-22   
Ofloxacin Ofloxacin  2008-03-17   
Tobramycin, Loteprednol etabonate Zylet  2004-12-14   
AllerganOfloxacin Ocuflox  1993-07-30   
Gatifloxacin Zymar  2003-03-28   
Ciprofloxacin Ciprofloxacin  2005-01-21   
BayerCiprofloxacin Cipro  1987-10-22   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
89%
8/9
Phase 3
56%
14/25
Approved: 6Overall Success rate: 50%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
Bausch Health Companies
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use